Viviana Gradinaru: Clearing the Way

Assistant Professor, Department of Biology and Biological Engineering, Caltech. Age: 33

kerry grens
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Photo © JIM CORNFIELDViviana Gradinaru spent her early childhood in a village of fewer than 100 subsistence farmers tucked into the countryside of northeastern Romania. Her family stressed the importance of education, whether in a classroom or in the hills outside her grandparents’ tiny village. “It was extremely enlightening in terms of freedom of play,” she recalls. Gradinaru’s interest in the natural world led her to study physics at the University of Bucharest, but she came to realize that she’d have more opportunities for experimentation abroad. So she transferred to Caltech in her second year to study biophysics in a neuroscience lab.

For graduate school Gradinaru joined the lab of Stanford University’s Karl Deisseroth because of his interest in developing neuroscience tools. “I left Caltech with this need to be able to control cell types in intact tissue,” she says. Deisseroth’s lab was beginning to develop optogenetics, and Gradinaru jumped on board to use the technique to figure out how deep-brain stimulation (DBS) benefits Parkinson’s patients.

Along the way, Gradinaru worked on a problem with trying to inhibit neuronal activity: the opsins, light-sensitive proteins that are the workhorses of optogenetics, would sometimes clump and damage cells. Though it was only a year-long detour en route to her PhD, the solution Gradinaru came up with is now fundamental to optogenetics, says Deisseroth. “She found a short amino acid ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • kerry grens

    Kerry Grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo